Related Experiment Video

Updated: Aug 23, 2026

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer
07:45

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Published on: May 18, 2020

[Therapeutic implications of advances in breast cancer biology]

François Bertucci1, Anthony Gonçalves, Dominique Maraninchi

  • 1Département d'oncologie médicale, département d'oncologie moléculaire, Institut Paoli-Calmettes, IFR57, 13273 Marseille 09. bertuccif@marseille.fnclcc.fr

La Revue Du Praticien
|July 28, 2004
PubMed

Insights

Breast cancer

Area of Science:

  • Genomics and molecular biology research.
  • Focus on cancer genetics and personalized medicine.

Context:

  • Breast cancer exhibits genetic heterogeneity, influencing tumor phenotype and patient outcomes.
  • Current therapies target hormonal and ERBB2 receptors, but limitations remain.
  • High-throughput technologies like DNA microarrays offer new analytical capabilities.

Purpose:

  • To leverage advanced genomic technologies for a deeper understanding of breast cancer heterogeneity.
  • To identify novel prognostic factors and therapeutic targets.
  • To improve patient stratification for tailored treatments.

Summary:

  • DNA microarrays enable simultaneous measurement of thousands of gene activities in breast tumors.
  • Gene expression profiling can reveal previously unrecognized tumor subgroups with distinct clinical outcomes.
  • This approach facilitates more precise patient stratification and the discovery of new therapeutic strategies.

Impact:

  • Enables more accurate prediction of patient prognosis.
  • Facilitates the development of targeted molecular therapies.
  • Advances personalized medicine approaches in oncology.

More Related Videos

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies09:01

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Published on: July 3, 2025

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...